Reversibility of <i>PRKAG2</i> Glycogen-Storage Cardiomyopathy and Electrophysiological Manifestations
Cordula M. Wolf(Friedrich-Alexander-Universität Erlangen-Nürnberg), Charles I. Berul(Children's National), Jeffrey Robbins(Cincinnati Children's Hospital Medical Center), Michael Arad(Tel Aviv University), Okan Toka(Harvard University), Ferhaan Ahmad(University of Iowa), Atsushi Sanbe(Iwate Medical University), Tetsuo Konno(Kanazawa University), Scott Bernstein(Heart Rhythm Society), Gregory E. Morley(Scripps Research Institute), J.G. Seidman(Howard Hughes Medical Institute), Christine E. Seidman(Harvard University)
Cited by 89
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k